ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669739 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669739; 2) Community: the network communities that were significantly associated with the response to NSC 669739; 3) Molecule: the relationships between components within communities and NSC 669739; 4) MDR: the compounds that were significantly associated with the NSC 669739.

NSC Compound Enrichment Correlation
NSC 69911 Null 0.00454081715455577 -0.080010082
NSC 755424 Null 0.00454081715455577 0.14145909
NSC 623879 Null 0.00577660600506179 0.086469013
NSC 688235 Null 0.00577660600506179 -0.067271758
NSC 746608 Null 0.00577660600506179 0.045189529
NSC 753585 N1-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]-2-2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxyacetamide 0.00577660600506179 0.36823849
NSC 756468 SB-725317 0.00577660600506179 0.27426407
NSC 92909 ANTINEOPLASTIC-92909 0.00577660600506179 -0.01733235
NSC 364170 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a 0.00628187335688605 -0.085920802
NSC 670852 8-Hydroxymanzamine A 0.00628187335688605 -0.14708701
Total:50  Current:5    [First] [Prev] [Next] [Last]